{"raw_mentions": "There are no sentences that meet the specified criteria. The text does not contain specific molecule names, bioactivity metrics (IC50, Ki, Kd, EC50), numeric values, and units in the same sentence. \n\nHowever, one sentence contains a Ki value and a molecule, but it lacks a numeric value and unit:\n\"...an IgFc scaffold (a KiHs-s IgFc)...\" \n\nThis sentence does not meet the specified criteria, so no sentences are returned."}
{"raw_mentions": "There are no sentences that meet the specified criteria. The text does not contain specific molecule names, IDs, or identifiers along with bioactivity metrics (IC50, Ki, Kd, EC50), numeric values, and units. The text primarily discusses the behavior and properties of constructs in a general sense, without providing specific data or measurements."}
{"raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n* An NBD for use in the constructs provided herein may have, for example, a dissociation constant for ATP from about an order of magnitude above (10 times above) the upper level found in the extracellular space of normal tissues (i.e., about 1 \u03bcM or higher) up to about the level of ATP found in the TME.\n* In some cases, the affinity of an NBD will be from about 1 \u03bcM to about 200 \u03bcM.\n* For example, the ATP affinity of an NBD may be in a range from about 1 \u03bcM to about 5 \u03bcM or from about 5 \u03bcM to about 25 \u03bcM.\n* The ATP affinity of an NBD may be in a range from about 10 \u03bcM to about 25 \u03bcM or from about 25 \u03bcM to about 200 \u03bcM.\n* The ATP affinity of an NBD may be in a range from about 25 \u03bcM to about 50 \u03bcM.\n* In other examples, the affinity of an NBD may be in a range from about 50 \u03bcM to about 100 \u03bcM or from about 100 \u03bcM to about 200 \u03bcM.\n* An NBD for use in the constructs provided herein may have, for example, a dissociation constant for ATP greater than about 5 \u03bcM or greater than about 10 \u03bcM."}
{"final_json": [{"molecule_name": "ATP", "protein_target_name": "NBD", "binding_metric": "dissociation constant", "value": ">1", "unit": "\u03bcM"}, {"molecule_name": "ATP", "protein_target_name": "NBD", "binding_metric": "affinity", "value": "1-200", "unit": "\u03bcM"}, {"molecule_name": "ATP", "protein_target_name": "NBD", "binding_metric": "affinity", "value": "1-5", "unit": "\u03bcM"}, {"molecule_name": "ATP", "protein_target_name": "NBD", "binding_metric": "affinity", "value": "5-25", "unit": "\u03bcM"}, {"molecule_name": "ATP", "protein_target_name": "NBD", "binding_metric": "affinity", "value": "10-25", "unit": "\u03bcM"}, {"molecule_name": "ATP", "protein_target_name": "NBD", "binding_metric": "affinity", "value": "25-200", "unit": "\u03bcM"}, {"molecule_name": "ATP", "protein_target_name": "NBD", "binding_metric": "affinity", "value": "25-50", "unit": "\u03bcM"}, {"molecule_name": "ATP", "protein_target_name": "NBD", "binding_metric": "affinity", "value": "50-100", "unit": "\u03bcM"}, {"molecule_name": "ATP", "protein_target_name": "NBD", "binding_metric": "affinity", "value": "100-200", "unit": "\u03bcM"}, {"molecule_name": "ATP", "protein_target_name": "NBD", "binding_metric": "dissociation constant", "value": ">5", "unit": "\u03bcM"}, {"molecule_name": "ATP", "protein_target_name": "NBD", "binding_metric": "dissociation constant", "value": ">10", "unit": "\u03bcM"}]}
{"raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n\nSubstitutions at positions S542 (e.g., S542A); Q586 (e.g., Q586A), C662 (e.g., C662S), D667 (e.g., D667A); and C735 (e.g., C735S) have been shown to alter the EC50 for ATP induced dimerization or higher order complex formation of TAP1 NBD containing constructs.\nThe NBD of TAP1 may comprise a substitution at D667 (e.g., D667A); and the NBDs of TAP2 and other ABC transporters may comprise a substitution (e.g., an alanine) at the corresponding aa position (see, e.g., construct 647).\nThe NBD of TAP1 may comprise a substitution at Q586 (e.g., Q586A); and the NBDs of TAP2 and other ABC transporters may comprise a substitution (e.g., an alanine) at the corresponding aa position (see, e.g., construct 648).\nTAP1, TAP2 and other ABC transporters may comprise substitutions that can affect the EC50 for ATP mediated dimerization or higher order complex formation of ABC transporters in the Q loop amino acids.\nTAP1, TAP2 and other ABC transporters may comprise substitutions that can affect the EC50 for ATP mediated dimerization or higher order complex formation of ABC transporters in the Walker region aas.\nTAP1, TAP2 and other ABC transporters may comprise substitutions that can affect the EC50 for ATP mediated dimerization or higher order complex formation of ABC transporters outside of the Walker region aas.\nTAP1, TAP2 and other ABC transporters may comprise substitutions of aas binding to the adenine or ribose of ATP that can affect the EC50 for ATP mediated dimerization or higher order complex formation of ABC transporters.\n\n\nNote that none of the extracted sentences contain a specific numeric value for the EC50 metric with a unit. If you would like to extract sentences with other bioactivity metrics (e.g. IC50, Ki, Kd), please let me know."}
{"final_json": [{"molecule_name": "ATP", "protein_target_name": "TAP1 NBD", "binding_metric": "EC50", "value": null, "unit": null}, {"molecule_name": null, "protein_target_name": "TAP1 NBD", "binding_metric": null, "value": null, "unit": null}, {"molecule_name": null, "protein_target_name": "TAP1 NBD", "binding_metric": null, "value": null, "unit": null}, {"molecule_name": "ATP", "protein_target_name": "TAP1, TAP2 and other ABC transporters", "binding_metric": "EC50", "value": null, "unit": null}, {"molecule_name": "ATP", "protein_target_name": "TAP1, TAP2 and other ABC transporters", "binding_metric": "EC50", "value": null, "unit": null}, {"molecule_name": "ATP", "protein_target_name": "TAP1, TAP2 and other ABC transporters", "binding_metric": "EC50", "value": null, "unit": null}, {"molecule_name": "ATP", "protein_target_name": "TAP1, TAP2 and other ABC transporters", "binding_metric": "EC50", "value": null, "unit": null}]}
{"raw_mentions": "IgG1 Fc sequences bearing those substitutions remain in soluble monomeric form capable of high affinity binding to Fc\u03b3RI (Kd on the order of 10 nM) and bind to the neonatal Fc receptor (FcRn) that prevents lysosomal degradation of antibodies thereby extending their in vivo half-life."}
{"final_json": [{"molecule_name": "IgG1 Fc", "protein_target_name": "Fc\u03b3RI", "binding_metric": "Kd", "value": "10", "unit": "nM"}, {"molecule_name": "IgG1 Fc", "protein_target_name": "FcRn", "binding_metric": null, "value": null, "unit": null}]}
{"raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n* The construct or composition may have an EC50 for ATP induced dimerization/complexation from about 0.1 \u03bcM to about 0.5 \u03bcM of ATP, or from about 0.5 \u03bcM to about 5.0 \u03bcM of ATP.\n* The construct or composition may also have an EC50 for ATP induced dimerization/complexation from about 5.0 \u03bcM to about 50 \u03bcM of ATP, or from about 50 \u03bcM to about 250 \u03bcM of ATP.\n* Generally, the highest target tissue specific action and lowest off target action may be obtained by selecting constructs having an EC50 from about 0.2 times to about the ATP concentration in the target tissue (e.g., up to about twice the concentration of ATP, in the target tissue), or about 0.4 times to about the ATP concentration in the target tissue, and at least 10 times the ATP concentration in non-target tissues.\n* The EC50 value for ATP-induced dimerization of constructs (or their NBDs) may be measured via Biolayer Interferometry (BLI) using an Octet Red 96e instrument (Pall ForteBio LLC, Freemont, CA) by observing the alteration in signal (i.e., the interference pattern of white light reflected from the biological layer constructed on a biosensor tip) in 20mM Tris-HCl, 150mM NaCl, 5mM MgCl2.6H2O Hexahydrate, 0.005% Tween (v/v) pH 7.0 at 20 to 24 \u00b0C at different ATP concentrations (e.g., by titration of ATP).\n* The midpoint of the ATP induced response of the BLI probe represents the EC50.\n* As the typical ATP concentration in non-target tissue is typically 0.01 \u00b5M to 0.1 \u03bcM (100nM) the EC50 ATP induced dimerization/complexation may be selected to be higher than in the non- target tissue ATP concentration range.\n* The concentration in target tissues such as the TME may be from about 50 to about 1,000 \u03bcM or even higher and the EC50 for ATP induced dimerization/complexation may be selected to be below, or at about the lower end of the target tissue concentration range to slightly above the concentration found in a target tissue.\n* Additionally, the constructs may also have an EC50 for ATP induced dimerization/complexation from about 250 \u03bcM ATP to about 1 mM ATP or more."}
{"final_json": [{"molecule_name": null, "protein_target_name": null, "binding_metric": "EC50", "value": "0.1", "unit": "\u03bcM"}, {"molecule_name": null, "protein_target_name": null, "binding_metric": "EC50", "value": "0.5", "unit": "\u03bcM"}, {"molecule_name": null, "protein_target_name": null, "binding_metric": "EC50", "value": "5.0", "unit": "\u03bcM"}, {"molecule_name": null, "protein_target_name": null, "binding_metric": "EC50", "value": "50", "unit": "\u03bcM"}, {"molecule_name": null, "protein_target_name": null, "binding_metric": "EC50", "value": "250", "unit": "\u03bcM"}, {"molecule_name": null, "protein_target_name": null, "binding_metric": "EC50", "value": "100", "unit": "nM"}, {"molecule_name": null, "protein_target_name": null, "binding_metric": "EC50", "value": "1", "unit": "mM"}]}
{"raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n1. The construct or composition of any one of aspects 1-218, wherein the EC50 of ATP for dimer or higher order complex formation is from about 0.05 \u03bcM to about 0.5 \u03bcM or from about 0.5 \u03bcM to about 5.0 \u03bcM.\n2. The construct or composition of any one of aspects 1-218, wherein the EC50 of ATP for dimer or higher order complex formation is from about 5.0 \u03bcM to about 50 \u03bcM or from about 50 \u03bcM to about 250 \u03bcM.\n3. The method of aspect 234, wherein the administering or contacting is conducted using a construct or composition with an EC50 for ATP induced dimerization or higher order complex formation that is less the concentration of ATP in the target tissue or TME, or less than 50% concentration of ATP in the target tissue or TME.\n4. The method of aspect 234, wherein the administering or contacting is conducted using a construct or composition with an EC50 for ATP induced dimerization or higher order complex formation that is less than 20% of the concentration of ATP in the target tissue or TME, or less than 5% concentration of ATP in the target tissue or TME.\n5. The method of any one of aspects 235-236, wherein the EC50 for ATP induced dimerization is greater than two times the ATP concentration in peritumoral tissue or greater than five times the ATP level in peritumoral tissue.\n6. The method of any one of aspects 235-236, wherein the EC50 for ATP induced dimerization is greater than ten times the ATP concentration in peritumoral tissue or greater than twenty-five times the ATP level in peritumoral tissue."}
{"final_json": [{"molecule_name": "ATP", "protein_target_name": null, "binding_metric": "EC50", "value": "0.05", "unit": "\u03bcM"}, {"molecule_name": "ATP", "protein_target_name": null, "binding_metric": "EC50", "value": "0.5", "unit": "\u03bcM"}, {"molecule_name": "ATP", "protein_target_name": null, "binding_metric": "EC50", "value": "5.0", "unit": "\u03bcM"}, {"molecule_name": "ATP", "protein_target_name": null, "binding_metric": "EC50", "value": "50", "unit": "\u03bcM"}, {"molecule_name": "ATP", "protein_target_name": null, "binding_metric": "EC50", "value": "250", "unit": "\u03bcM"}, {"molecule_name": "ATP", "protein_target_name": null, "binding_metric": "EC50", "value": "< 50%", "unit": null}, {"molecule_name": "ATP", "protein_target_name": null, "binding_metric": "EC50", "value": "< 20%", "unit": null}, {"molecule_name": "ATP", "protein_target_name": null, "binding_metric": "EC50", "value": "< 5%", "unit": null}, {"molecule_name": "ATP", "protein_target_name": null, "binding_metric": "EC50", "value": "> 2 times", "unit": null}, {"molecule_name": "ATP", "protein_target_name": null, "binding_metric": "EC50", "value": "> 5 times", "unit": null}, {"molecule_name": "ATP", "protein_target_name": null, "binding_metric": "EC50", "value": "> 10 times", "unit": null}, {"molecule_name": "ATP", "protein_target_name": null, "binding_metric": "EC50", "value": "> 25 times", "unit": null}]}
{"raw_mentions": "The EC50 for ATP was determined for each of the three constructs (constructs 533:571, 533:647, and 533:648, see FIG.21 at A) by measuring the dimerization-induced mesothelin binding constants across a range of ATP concentrations (0.1 to 100 mM) using Biolayer Interferometry (BLI).\nMore specifically, mesothelin was immobilized onto streptavidin (SAX) biosensors in equilibration buffer 20mM Tris, 150mM NaCl, 5mM MgCl<sub>2</sub>.6H2O Hexahydrate, 0.005% Tween pH 7.0, and the indicated concentrations of ADP or ATP. \nThe results are provided in FIG.21 at B and demonstrate that constructs responding to different levels of ATP over four orders of magnitude can be prepared though mutations of amino acid residues having direct interactions with ATP or indirect interactions with ATP, such as mutations affecting the nucleotide-binding cofactor magnesium.\nsamples of the constructs (at 5, 10, and 20 nM) were then added and the sample allowed to equilibrate with the biosensor.\nThe dissociation rate constants (kdis) at each concentration were the measured by following the rate of signal decline upon replacing the equilibration buffer containing construct with equilibration buffer containing ATP at the indicated concentration but without any construct present."}
{"final_json": [{"molecule_name": "ATP", "protein_target_name": null, "binding_metric": "EC50", "value": null, "unit": "mM"}, {"molecule_name": "ADP", "protein_target_name": null, "binding_metric": null, "value": null, "unit": null}, {"molecule_name": "ATP", "protein_target_name": null, "binding_metric": null, "value": "0.1 to 100", "unit": "mM"}, {"molecule_name": "mesothelin", "protein_target_name": null, "binding_metric": null, "value": null, "unit": null}, {"molecule_name": "ATP", "protein_target_name": null, "binding_metric": null, "value": "5, 10, and 20", "unit": "nM"}, {"molecule_name": null, "protein_target_name": null, "binding_metric": "kdis", "value": null, "unit": null}]}
